Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K4OC
|
|||
| Former ID |
DIB006381
|
|||
| Drug Name |
DI-VAL-L-DC
|
|||
| Synonyms |
L-Valine 3',5'-diester with 4-amino-1-(2-deoxy-beta-L-erythro-pentofuranosyl)-2(1H)-pyrimidinone
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H31N5O6
|
|||
| Canonical SMILES |
CC(C)C(C(=O)OCC1C(CC(O1)N2C=CC(=NC2=O)N)OC(=O)C(C(C)C)N)N
|
|||
| InChI |
1S/C19H31N5O6/c1-9(2)15(21)17(25)28-8-12-11(30-18(26)16(22)10(3)4)7-14(29-12)24-6-5-13(20)23-19(24)27/h5-6,9-12,14-16H,7-8,21-22H2,1-4H3,(H2,20,23,27)/t11-,12+,14+,15+,16+/m1/s1
|
|||
| InChIKey |
BPPMYUZIZUESBY-MLEONAHRSA-N
|
|||
| CAS Number |
CAS 380886-96-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00128544) Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.